We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Improved Investment Banking Aid BofA (BAC) Q4 Earnings?
Read MoreHide Full Article
Performance of investment banking (IB), one of the key sources of revenues for Bank of America (BAC - Free Report) , is likely to have been decent in fourth-quarter 2019. So, this will to some extent aid the bank’s results, slated on Jan 15.
IB income basically comprises advisory fees (generated from M&A deals and IPOs) and underwriting revenues (equity and debt issuances). So, let’s check how these are likely to have been in the to-be-reported quarter.
Low interest rates and gradual easing of geopolitical concerns are expected to have offered support to IB fees. Though the number of closed deals declined during the fourth quarter, a higher number of announced M&As indicate a strong pipeline.
Global deal value declined as well. This likely had an adverse impact on BofA’s advisory fees. However, as the bank is one of the leading players in this space and has higher focus on M&A business, this must have provided some leverage.
Now coming to underwriting fees, solid equity market performance and the central banks’ accommodative stance are likely to have driven corporates to issue equities globally. Similarly, IPO activities witnessed an uptrend during the to-be-reported quarter.
Also, bond issuance volumes were solid, while debt issuances were muted as corporate loan demand was weak. Therefore, growth in BofA’s equity underwriting fees and debt origination fees (accounting for nearly 40% of total IB fees) is likely to have been decent in the fourth quarter.
At the investors' conference in December 2019, CEO Brian Moynihan had projected IB revenues to rise 3-4% on a year-over-year basis.
BofA’s IB revenues are accounted in the Global Banking segment. The Zacks Consensus Estimate for the segment’s net revenues of $5.05 billion suggests a slight decline from the year-ago reported figure.
Earnings & Revenue Expectations
For BofA, the Zacks Consensus Estimate for earnings of 68 cents suggests a 2.9% decrease from the year-ago reported number. Also, the consensus estimate for sales of $22 billion indicates a fall of 3.2%.
Bank of America Corporation Price and EPS Surprise
Click here to know about a few other factors that are likely to have impacted BofA’s earnings.
Our Take
Amid lower interest rates and soft corporate lending, decent IB performance is likely to have had a positive effect on BofA’s top-line growth. Along with this, solid trading performance will offer some support to this Zacks Rank #2 (Buy) stock.
During an investor conference in December, JPMorgan’s (JPM - Free Report) CFO, Jennifer Piepszak, projected IB revenues to be flat on a year-over-year basis. Further, she had noted, “The quarter has played out a little bit better than we thought largely on healthy investment grade flow given the rate environment. Important to note there that the wallet is shrinking.”
At the same conference, Citigroup’s (C - Free Report) CFO Mark Mason projected IB revenues to be flat to slightly down from the prior-year quarter. He had, further, stated “We expect to continue to take share,” though wallets are declining.
Similar to the above-mentioned banks, IB revenues form a large portion of total revenues for Goldman Sachs and Morgan Stanley (MS - Free Report) . Hence, improved IB performance is expected to have aided these banks’ revenues and earnings in the fourth quarter.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Can Improved Investment Banking Aid BofA (BAC) Q4 Earnings?
Performance of investment banking (IB), one of the key sources of revenues for Bank of America (BAC - Free Report) , is likely to have been decent in fourth-quarter 2019. So, this will to some extent aid the bank’s results, slated on Jan 15.
IB income basically comprises advisory fees (generated from M&A deals and IPOs) and underwriting revenues (equity and debt issuances). So, let’s check how these are likely to have been in the to-be-reported quarter.
Low interest rates and gradual easing of geopolitical concerns are expected to have offered support to IB fees. Though the number of closed deals declined during the fourth quarter, a higher number of announced M&As indicate a strong pipeline.
Global deal value declined as well. This likely had an adverse impact on BofA’s advisory fees. However, as the bank is one of the leading players in this space and has higher focus on M&A business, this must have provided some leverage.
Now coming to underwriting fees, solid equity market performance and the central banks’ accommodative stance are likely to have driven corporates to issue equities globally. Similarly, IPO activities witnessed an uptrend during the to-be-reported quarter.
Also, bond issuance volumes were solid, while debt issuances were muted as corporate loan demand was weak. Therefore, growth in BofA’s equity underwriting fees and debt origination fees (accounting for nearly 40% of total IB fees) is likely to have been decent in the fourth quarter.
At the investors' conference in December 2019, CEO Brian Moynihan had projected IB revenues to rise 3-4% on a year-over-year basis.
BofA’s IB revenues are accounted in the Global Banking segment. The Zacks Consensus Estimate for the segment’s net revenues of $5.05 billion suggests a slight decline from the year-ago reported figure.
Earnings & Revenue Expectations
For BofA, the Zacks Consensus Estimate for earnings of 68 cents suggests a 2.9% decrease from the year-ago reported number. Also, the consensus estimate for sales of $22 billion indicates a fall of 3.2%.
Bank of America Corporation Price and EPS Surprise
Bank of America Corporation price-eps-surprise | Bank of America Corporation Quote
Click here to know about a few other factors that are likely to have impacted BofA’s earnings.
Our Take
Amid lower interest rates and soft corporate lending, decent IB performance is likely to have had a positive effect on BofA’s top-line growth. Along with this, solid trading performance will offer some support to this Zacks Rank #2 (Buy) stock.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
IB Fee Projections for Other Banks
During an investor conference in December, JPMorgan’s (JPM - Free Report) CFO, Jennifer Piepszak, projected IB revenues to be flat on a year-over-year basis. Further, she had noted, “The quarter has played out a little bit better than we thought largely on healthy investment grade flow given the rate environment. Important to note there that the wallet is shrinking.”
At the same conference, Citigroup’s (C - Free Report) CFO Mark Mason projected IB revenues to be flat to slightly down from the prior-year quarter. He had, further, stated “We expect to continue to take share,” though wallets are declining.
Similar to the above-mentioned banks, IB revenues form a large portion of total revenues for Goldman Sachs and Morgan Stanley (MS - Free Report) . Hence, improved IB performance is expected to have aided these banks’ revenues and earnings in the fourth quarter.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>